Morgan Stanley Call 285 CHTR 20.0.../ DE000MG0G519 /
21/06/2024 20:33:48 | Diferencia+0.16 | Bid22:00:35 | Ask22:00:35 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
1.23EUR | +14.95% | - Volumen de oferta: - |
- Tamaño/ Volumen/ Formato de Ask: - |
Charter Communicatio... | 285.00 USD | 20/09/2024 | Call |
GlobeNewswire
7:30
PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for u...
GlobeNewswire
7:30
OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell...
GlobeNewswire
7:00
Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ®
GlobeNewswire
6:20
China's Hangzhou empowers urban development with world-class power supply reliability
GlobeNewswire
3:00
SALESFORCE ALERT: Bragar Eagel & Squire, P.C. is Investigating Salesforce, Inc. on Behalf of Salesfo...
GlobeNewswire
3:00
NIKE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against...
GlobeNewswire
3:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página